Enterprise Value
2.699M
Cash
9.809M
Avg Qtr Burn
-5.228M
Short % of Float
2.99%
Insider Ownership
1.15%
Institutional Own.
3.57%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
IMNN-001 (GEN-1) +/- bevacizumab Details Ovarian cancer, Cancer | Phase 1/2 Data readout | |
IMNN-101 Details COVID-19 | Phase 1 Data readout | |
ThermoDox Details Cancer, Liver cancer | Failed Discontinued |